Pro-BNP Levels and Its Prognostic Role in Chronic Hypertensive Pregnancies: A Prospective Case-Control Study From A Tertiary Care Hospital

References

• Seely EW, Ecker J. Chronic hypertension in pregnancy. Circulation. 2014;129(11):1254–1261.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics. ACOG practice bulletin no. 203: chronic Hypertension in Pregnancy. Obstet Gynecol. 2019;133(1):e26–e50. .
   PubMed Web of Science ®Google Scholar
• Junus K, Wikstrom AK, Larsson A, et al. Early second-trimester plasma levels of NT-proBNP in women who subsequently develop early-onset preeclampsia. J Matern Fetal Neonatal Med. 2017;30(18):2163–2165.
   PubMed Web of Science ®Google Scholar
• Fleming SM, O’Byrne L, Grimes H, et al. Amino-terminal pro-brain natriuretic peptide in normal and hypertensive pregnancy. Hypertens Pregnancy. 2001;20(2):169–175.
   PubMed Web of Science ®Google Scholar
• Sadlecki P, Grabiec M, Walentowicz-Sadlecka M. Prenatal clinical assessment of NT-proBNP as a diagnostic tool for preeclampsia, gestational hypertension and gestational diabetes mellitus. PloS One. 2016;11(9):e0162957.
   PubMed Web of Science ®Google Scholar
• Yi H, Zhang WZ, Zhang H, et al. Subclinical target organ damage in normotensive and prehypertensive patients. Minerva Cardioangiol. 2017;65(1):16–23.
   PubMed Web of Science ®Google Scholar
• Faul F, Erdfelder E, Buchner A, et al. Statistical power analyses using G* Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41(4):1149–1160.
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, et al. ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104.
   PubMed Web of Science ®Google Scholar
• Brown MA, Magee LA, Kenny LC, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72(1):24–43. .
   PubMed Web of Science ®Google Scholar
• Bateman BT, Bansil P, Hernandez-Diaz S, et al. Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions. Am J Obstet Gynecol. 2012;206(2):134.e1–8.
   Web of Science ®Google Scholar
• Panaitescu AM, Syngelaki A, Prodan N, et al. Chronic hypertension and adverse pregnancy outcome: a cohort study. Ultrasound Obstetrics Gynecol. 2017;50(2):228–235.
   PubMedGoogle Scholar
• Zetterström K, Lindeberg SN, Haglund B, et al. Maternal complications in women with chronic hypertension: a population-based cohort study. Acta Obstet Gynecol Scand. 2005;84(5):419–424.
   PubMed Web of Science ®Google Scholar
• Onalan G, Terzi YK, Tohma YA, et al. Placental maspin gene expression pattern may be used to distinguish between preeclampsia and intrauterine growth restriction. Gynecology Obstet Reprod Med. 2020:1–5. DOI:https://doi.org/10.21613/GORM.2019.969.
   Google Scholar
• Chahine KM, Sibai BM. Chronic hypertension in pregnancy: new concepts for classification and management. Am J Perinatol. 2019;36(02):161–168.
   PubMedGoogle Scholar
• Podymow T, August P. New Evidence in the management of chronic hypertension in pregnancy. Semin Nephrol. 2017 Jul;37(4):398-403. DOI: https://doi.org/10.1016/j.semnephrol.2017.05.012. PMID: 28711079.
   Google Scholar
• Kilicci C, Yayla Abide C, Ozkaya E, et al. Confounders for neonatal intensive care unit admission in neonates of mothers with preeclampsia. Gynecology Obstet Reprod Med. 2018;24(3):162–166. .
   Google Scholar
• Boriboonhirunsarn D, Pradyachaipimol A, Viriyapak B. Incidence of superimposed preeclampsia among pregnant Asian women with chronic hypertension. Hypertens Pregnancy. 2017;36(2):226–231.
   PubMed Web of Science ®Google Scholar
• Paré E, Parry S, McElrath TF, et al. Clinical risk factors for preeclampsia in the 21st century. Obstetrics Gynecol. 2014;124(4):763–770.
   PubMed Web of Science ®Google Scholar
• Poon LC, Nicolaides KH. Early prediction of preeclampsia. Obstet Gynecol Int. 2014;2014:1–11.
   PubMedGoogle Scholar
• Myatt L, Clifton RG, Roberts JM, et al. First-trimester prediction of preeclampsia in low-risk nulliparous women. Obstet Gynecol. 2012;119(6):1234.
   PubMed Web of Science ®Google Scholar
• Cerdeira AS, O’Sullivan J, Ohuma EO, et al. Randomized interventional study on prediction of preeclampsia/eclampsia in women with suspected preeclampsia: INSPIRE. Hypertension. 2019;74(4):983–990. .
   PubMed Web of Science ®Google Scholar
• Fujioka K, Mizobuchi M, Sakai H, et al. N-Terminal pro-brain natriuretic peptide levels in dichorionic diamniotic twins with selective intrauterine growth restriction. Kobe J Med Sci. 2013;59(4):E141–E8.
   Google Scholar
• Bahlmann F, Krummenauer F, Spahn S, et al. Natriuretic peptide levels in intrauterine growth-restricted fetuses with absent and reversed end-diastolic flow of the umbilical artery in relation to ductus venosus flow velocities. J Perinat Med. 2011;39(5):529–537.
   PubMed Web of Science ®Google Scholar
• De Souza LR, Ye C, Hanley AJ, et al. Circulating B‐type natriuretic peptide in women with and without recent gestational diabetes: the impact of current glucose intolerance. Clin Endocrinol (Oxf). 2018;88(2):227–233. .
   PubMed Web of Science ®Google Scholar
• Yu L, Zhou Q, Peng Q, et al. Left ventricular function of patients with pregnancy‐induced hypertension evaluated using velocity vector imaging echocardiography and N‐terminal pro‐brain natriuretic peptide. Echocardiography. 2018;35(4):459–466.
   PubMed Web of Science ®Google Scholar
• Ghomian, N., Vakilian, F., Shahri, B., Rostaminejad, V., & Khadem-Rezaiyan, M. Can brain natriuretic peptide predict cardiovascular complications in severe preeclampsia? A case-control study. Int J Reprod Biomed. 2019;17(4):271–278. https://doi.org/10.18502/ijrm.v17i4.4552.
   Google Scholar
• Yu L, Zhou Q, Peng Q, et al. Velocity vector imaging echocardiography and NT‐proBNP study of fetal cardiac function in pregnancy‐induced maternal hypertension. Clin Ultrasound. 2019;47(5):285–291.
   PubMed Web of Science ®Google Scholar
• Kale A, Kale E, Yalinkaya A, et al. The comparison of amino-terminal probrain natriuretic peptide levels in preeclampsia and normotensive pregnancy. J Perinat Med. 2005;33(2):121–124.
   PubMed Web of Science ®Google Scholar
• Kumari M, Kovach T, Sheehy B, et al. Circulating NT-proBNP but not soluble corin levels were associated with preeclampsia in pregnancy-associated hypertension. Clin Biochem. 2019;67:12–15.
   PubMed Web of Science ®Google Scholar
• Hamad RR, Larsson A, Pernow J, et al. Assessment of left ventricular structure and function in preeclampsia by echocardiography and cardiovascular biomarkers. J Hypertens. 2009;27(11):2257–2264.
   PubMed Web of Science ®Google Scholar
• Uyar İ, Kurt S, Demirtaş Ö, et al. The value of uterine artery doppler and NT-proBNP levels in the second trimester to predict preeclampsia. Arch Gynecol Obstet. 2015;291(6):1253–1258. .
   PubMed Web of Science ®Google Scholar
• Selvaratnam RJ, Wallace EM, Flenady V, et al. Risk factor assessment for fetal growth restriction, are we providing best care? Aust NZ J Obstetrics Gynaecol. 2020;60(3):470–473.
   PubMed Web of Science ®Google Scholar
• Monier I, Blondel B, Ego A, et al. Does the presence of risk factors for fetal growth restriction increase the probability of antenatal detection? A french national study. Paediatr Perinat Epidemiol. 2016;30(1):46–55.
   PubMed Web of Science ®Google Scholar
• Fitton CA, Steiner MF, Aucott L, et al. In-utero exposure to antihypertensive medication and neonatal and child health outcomes: a systematic review. J Hypertens. 2017;35(11):2123. .
   PubMed Web of Science ®Google Scholar
• Fitton CA, Fleming M, Steiner MF, et al. In utero antihypertensive medication exposure and neonatal outcomes: a data linkage cohort study. Hypertension. 2020;75(3):628–633. .
   PubMed Web of Science ®Google Scholar
• Bettiol A, Avagliano L, Lombardi N, et al. Pharmacological interventions for the prevention of fetal growth restriction: a systematic review and network meta-analysis. Clin Pharmacol Ther. 2021. DOI:https://doi.org/10.1002/cpt.2164.
   Google Scholar
• Mather AR, Dom AM, Thorburg LL. Low-dose aspirin in pregnancy: who? when? how much? and why? Curr Opin Obstet Gynecol. 2021;33(2):65–71.
   PubMed Web of Science ®Google Scholar